Mode
Text Size
Log in / Sign up
Phase 3 N=181 Randomized Single-blind Other

Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery

Opioid Use, Unspecified · Bariatric Surgery Candidate · Anesthesia

Enrolled (actual)
181
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcome: Primary: 24 Hour Opioid Consumption — 51; 55; 27; 32 mg oral morphine equivalents (OMEs)

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Opioid Anesthetics (Drug); Non Opioid Analgesics (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Christine Oryhan
Primary completion
Mar 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
24 Hour Opioid Consumption
51; 55; 27; 32
SECONDARY
Length of Time Under General Anesthesia
3.47; 3.32
SECONDARY
Percentage of Patients With Opioid-related Adverse Effects
19; 16; 2; 4; 21; 29
SECONDARY
Length of Time to Recover From General Anesthesia
1.33; 1.41
SECONDARY
Length of Hospital Stay
1.45; 1.58
SECONDARY
Overall Patient Satisfaction With Analgesia: Yes or no
73; 72
SECONDARY
Number of Participants With Post-surgical Opioid Prescription Refills up to 30 Days
9; 10
SECONDARY
Percentage of Patients Treated for General Anesthetic Adverse Effects
10; 17; 41; 67; 28; 54
SECONDARY
Number of Participants With Post-surgical Opioid Prescription Refills Between 30 Days to 3 Months After Surgery
8; 4

Summary

A comparison of post-operative opioid use in laparoscopic bariatric surgery patients receiving opioid or opioid-free anesthesia.

Eligibility Criteria

Inclusion Criteria

  • Adult patients undergoing elective laparoscopic bariatric surgery (i.e. laparoscopic roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy) able to provide informed consent

Exclusion Criteria

  • Any opioid use within 4 weeks prior to surgery
  • Chronic antiemetic use
  • Conversion of laparoscopic to open surgery
  • Patients unable to provide post-operative pain scores
  • Pregnant or lactating patients
  • Patients under 18 years of age
  • Refusal or inability to provide informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04081545). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search